Company intelligence / Profile preview

Kocak Medical & Laboratory

Çerkezköy, Turkey

Ownership: Private
Employees: ~1800
Development stage: Other

Overview

Leader in biotechnology and oncology in Turkey; launched first biosimilar (Enoxaparin Sodium) in EU and Turkey in 2012; launched first locally manufactured Insulin (Glarin) in 2017

Therapeutic areas: Women's HealthCardiovascularInfectious DiseasesRheumatologyPulmonologyOncologyMen's Health
Modalities: Small moleculeMonoclonal antibodyVaccineRecombinant protein
Industry: Biotech

Partnerships

Cooperates with leading European companies for product development and marketing

Beyond the preview

Go deeper on Kocak Medical & Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kocak Medical & Laboratory.

Explore the full profile